Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies.

Rheumatol Int · 2016 · PMC4839046 · PMID 26892034

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Continuous efficacy was noted for HAQ-DI, enthesitis and dactylitis (even if the improvement of the last two clinical features did not reach statistical significance at week 24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.